DEVELOPMENT OF A BACTERICIDAL, LONG-HALF-LIFE, OSPA-SPECIFIC HUMAN MONOCLONAL ANTIBODY AS A NOVEL PRE-EXPOSURE PROPHYLAXIS (PREP) FOR LYME DISEASE

University Of Massachusetts Medical School, Worcester MA

Investigators